Onglyza
In the US, Onglyza (saxagliptin systemic) is a member of the drug class dipeptidyl peptidase 4 inhibitors and is used to treat Diabetes, Type 2.
US matches:
UK matches:
Ingredient matches for Onglyza
Saxagliptin is reported as an ingredient of Onglyza in the following countries:
- Italy
- Norway
Saxagliptin hydrochloride (a derivative of Saxagliptin) is reported as an ingredient of Onglyza in the following countries:
- Austria
- Belgium
- Canada
- Chile
- Croatia (Hrvatska)
- Finland
- France
- Germany
- Greece
- Latvia
- Lithuania
- Mexico
- Netherlands
- Philippines
- Slovenia
- Spain
- Sweden
- Switzerland
- Taiwan
- United Kingdom
- United States
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
